De La Rosa Abel 4
4 · Virios Therapeutics, Inc. · Filed Feb 28, 2024
Insider Transaction Report
Form 4
De La Rosa Abel
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-26+3,959→ 3,959 totalExercise: $0.36Exp: 2034-02-26→ Common Stock (3,959 underlying)
Footnotes (1)
- [F1]The stock option will vest 100% on February 26, 2025, one year following the grant date.